A new law will let Medicare bargain for the first time. But a health policy scholar explains why it’s unlikely to make much of a difference in how much seniors – or anyone else – pays for their meds.
Some biologics can cost up to a million dollars for a year’s worth.
Tero Vesalainen
Biologics, therapies made inside or of living cells, are a growing share of pharmaceutical sales. But the cost of these miracle treatments makes them unaffordable for many. New FDA guidance may help.
Miniature biomanufacturing kits like this prototype could revolutionize the pharmaceutical industry.
Amino Labs
Small-batch brewers are starting to tinker with biologic drugs to meet their own medical needs. A side effect of their success would be a disruption to how big pharma makes and distributes drugs.
Heather Bresch, CEO of Mylan, holds two EpiPens as she testified before Congress Sept. 21, 2016 about rising costs of the drug.
AP Photo/Pablo Martinez Monsivais
The rising costs of generic drugs have led to outcries. In a search for solutions, four hospital systems are proposing to make drugs on their own. Could their idea work?